Please read and agree to the
terms and conditions
of this site.
I agree
Funding Series
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trial
fda
glaxosmithkline
2
×
ipo
2
×
life sciences
national blog main
new york blog main
2025
ad-comm
affimed
aju ib investment
akcea therapeutics
allogene therapeutics
amgen ventures. 6 dimensions capital
amicus therapeutics
approval
apremilast
arvinas
atlas venture
auto-inflammatory disorder
autoimmune disease
base editing
bessemer venture partners
bio
biogen
biome
blueprint medicineas
boston
boulder/denver blog main
boulder/denver top stories
briefing docs
c4 therapeutics
cancer
car-t
cedilla therapeutics
celgene
cervical cancer
What
new
therapeutics
2
×
adds
allogene
bio
breaking
built
cancer
cells
clinical
crispr
damaged
diversity
eyes
funding
harness
hot
immunotherapy
investors
ipo
juno
kymera
million
nearly
process
proteins
remains
roundup
shares
snapped
test
therapy
ticket
trying
unneeded
using
utero
way
years
Language
Current search:
therapeutics
×
ipo
×
glaxosmithkline
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}